Zimmer Biomet Keeps Focus on Innovation and New Products

The last few years have become a time of change for Zimmer Biomet. In 2017, Bryan Hanson became the new president and CEO of Zimmer Biomet. Hanson’s mission was to get the company back on track after disappointing performance in some quarters. Currently the Warsaw, IN-based company is making strides in this effort by getting regulatory approvals and clearances for its products. The latest offering from Zimmer Biomet to be cleared by FDA is the Augmented Baseplate. The company said it had recently completed the first surgical case using the technology with positive results. “These implants allow the surgeons to maintain that good bone integrity, while addressing the deformity,” Orsa Britton, vice president and general manager of Zimmer Biomet’s global Extremities business, told MD+DI. Join us at the BIOMEDevice Boston Expo,  April 18–19, 2018. Use promo code "MDDI" for 20% off conference registration and free expo access.   The baseplate offers an alternative to bone grafting and eccentric reaming for patients with glenoid defects undergoing shoulder reconstruction. The company said the baseplate boasts a simplified circular design at three augment heights (3mm, 5mm and 7mm buildup), allowing for augment placement in any orientation to accommodate various unique bone anatomies. Its circular design also allows bone ingrowth into the rim of the baseplate for optimal fixation.  “Most of the patients that need the implant are going to need a reverse shoulder, and t...
Source: MDDI - Category: Medical Devices Authors: Tags: Business Design News Source Type: news